These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18986020)

  • 41. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea.
    Kim HY; Uh Y
    Yonsei Med J; 2004 Aug; 45(4):591-7. PubMed ID: 15344198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil.
    Souza VC; Kegele FC; Souza SR; Neves FP; de Paula GR; Barros RR
    Scand J Infect Dis; 2013 Oct; 45(10):780-5. PubMed ID: 23876189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging erythromycin resistance among group B streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Yoon KJ; Song W
    Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):52-4. PubMed ID: 11245325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae.
    Nakamura PA; Schuab RB; Neves FP; Pereira CF; Paula GR; Barros RR
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):119-22. PubMed ID: 21537668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci.
    Tang P; Ng P; Lum M; Skulnick M; Small GW; Low DE; Sarabia A; Mazzulli T; Wong K; Simor AE; Willey BM
    J Clin Microbiol; 2004 May; 42(5):2282-4. PubMed ID: 15131213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial resistance in group B streptococcus: the Australian experience.
    Garland SM; Cottrill E; Markowski L; Pearce C; Clifford V; Ndisang D; Kelly N; Daley AJ
    J Med Microbiol; 2011 Feb; 60(Pt 2):230-235. PubMed ID: 21030500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevalence of anal-vaginal colonization of Streptococcus agalactiae in third trimester of pregnancy and susceptibility to macrolides and lincosamides, in pregnant women controlled at Clínica Alemana Temuco, Southern Chile].
    Abarzúa F; Argomedo C; Meissner A; Díaz T; Garrido P; Fariña S; Chahin C
    Rev Chilena Infectol; 2014 Jun; 31(3):305-8. PubMed ID: 25146205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Problems with identification of beta-hemolytic streptococcus resistant to bacitracin isolated from patients with pharyngitis].
    Olender A; Łetowska I; Karyński M; Kiernicka-Ciekot K; Pels K
    Med Dosw Mikrobiol; 2012; 64(1):1-10. PubMed ID: 22808724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid determination of macrolide and lincosamide resistance in group B streptococcus isolated from vaginal-rectal swabs.
    Dela Cruz WP; Richardson JY; Broestler JM; Thornton JA; Danaher PJ
    Infect Dis Obstet Gynecol; 2007; 2007():46581. PubMed ID: 17710240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.
    Gygax SE; Schuyler JA; Kimmel LE; Trama JP; Mordechai E; Adelson ME
    Antimicrob Agents Chemother; 2006 May; 50(5):1875-7. PubMed ID: 16641466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antimicrobial susceptibilities and serotype distribution of Streptococcus agalactiae strains isolated from pregnant women].
    Yenişehirli G; Bulut Y; Demirtürk F; Calişkan AC
    Mikrobiyol Bul; 2006 Jul; 40(3):155-60. PubMed ID: 17001843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular epidemiology of Streptococcus agalactiae recovered from significant bacteriuria.
    Schuab RB; Arêas GP; Souza VC; Barros RR
    Infect Dis (Lond); 2015 Sep; 47(9):637-42. PubMed ID: 25901729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Susceptibility patterns and mechanisms of macrolide resistance in group B streptococcus isolates].
    Shen AD; Zhang GR; Wang YH; Yang YH
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):661-4. PubMed ID: 16191298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.
    Betriu C; Casado MC; Gómez M; Sanchez A; Palau ML; Picazo JJ
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):255-60. PubMed ID: 10212752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.
    de Azavedo JC; McGavin M; Duncan C; Low DE; McGeer A
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3504-8. PubMed ID: 11709331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY PATTERNS OF STREPTOCOCCUS AGALACTIAE.
    Rigvava S; Kharebava S; Giorgobiani T; Dvalidze T; Goderdzishvili M
    Georgian Med News; 2019 Dec; (297):149-153. PubMed ID: 32011312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolving antibiotic resistance in Group B Streptococci causing invasive infant disease: 1970-2021.
    Sabroske EM; Iglesias MAS; Rench M; Moore T; Harvey H; Edwards M; Baker CJ; Flores AR
    Pediatr Res; 2023 Jun; 93(7):2067-2071. PubMed ID: 36352262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.